| Primary |
| Diabetes Mellitus |
57.1% |
| Type 2 Diabetes Mellitus |
14.8% |
| Hypertension |
6.3% |
| Diabetes Mellitus Non-insulin-dependent |
4.0% |
| Type 1 Diabetes Mellitus |
3.9% |
| Diabetes Mellitus Insulin-dependent |
2.2% |
| Abdominal Pain Upper |
1.2% |
| Cardiac Disorder |
1.2% |
| Gestational Diabetes |
1.2% |
| Pain |
1.2% |
| Neuropathy Peripheral |
1.1% |
| Blood Glucose Increased |
1.0% |
| Blood Pressure |
0.9% |
| Anticoagulant Therapy |
0.6% |
| Back Pain |
0.6% |
| Blood Cholesterol |
0.6% |
| Supplementation Therapy |
0.6% |
| Infection |
0.5% |
| Nervousness |
0.5% |
| Gastrointestinal Disorder |
0.5% |
|
| Visual Acuity Reduced |
14.5% |
| Weight Decreased |
8.1% |
| Myocardial Infarction |
7.6% |
| Death |
5.4% |
| Renal Failure |
5.4% |
| Pharmaceutical Product Complaint |
5.2% |
| Tremor |
4.9% |
| Cerebrovascular Accident |
4.7% |
| Vomiting |
4.4% |
| Weight Increased |
4.4% |
| Hospitalisation |
4.2% |
| Visual Impairment |
4.2% |
| Vision Blurred |
3.9% |
| Drug Ineffective |
3.7% |
| Blindness |
3.4% |
| Blood Glucose Increased |
3.4% |
| Loss Of Consciousness |
3.2% |
| Poor Quality Drug Administered |
3.2% |
| Wrong Technique In Drug Usage Process |
3.2% |
| Blood Glucose Decreased |
2.9% |
|
| Secondary |
| Diabetes Mellitus |
50.6% |
| Type 2 Diabetes Mellitus |
20.1% |
| Hypertension |
5.4% |
| Type 1 Diabetes Mellitus |
5.0% |
| Diabetes Mellitus Non-insulin-dependent |
2.9% |
| Nervousness |
1.4% |
| Gastrointestinal Disorder |
1.4% |
| Infection |
1.3% |
| Neuropathy Peripheral |
1.3% |
| Constipation |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Blood Pressure |
1.1% |
| Back Pain |
1.1% |
| Cardiac Disorder |
1.1% |
| Convulsion Prophylaxis |
0.9% |
| Anticoagulant Therapy |
0.9% |
| Cerebral Infarction |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Prophylaxis |
0.8% |
| Pain |
0.7% |
|
| Visual Acuity Reduced |
16.5% |
| Weight Decreased |
10.3% |
| Renal Transplant |
9.6% |
| Weight Increased |
7.7% |
| Blood Glucose Increased |
5.0% |
| Renal Failure |
4.8% |
| Multiple Allergies |
4.3% |
| Upper Respiratory Tract Infection |
4.1% |
| Myocardial Infarction |
3.8% |
| Poor Quality Drug Administered |
3.8% |
| Tremor |
3.8% |
| Diabetes Mellitus Inadequate Control |
3.3% |
| Vision Blurred |
3.3% |
| Visual Impairment |
3.3% |
| Cerebrovascular Accident |
2.9% |
| Loss Of Consciousness |
2.9% |
| Vomiting |
2.9% |
| Blood Glucose Decreased |
2.6% |
| Neuropathy Peripheral |
2.6% |
| Drug Ineffective |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.8% |
| Product Used For Unknown Indication |
24.2% |
| Diabetes Mellitus |
11.5% |
| Diabetes Mellitus Non-insulin-dependent |
7.6% |
| Hypertension |
6.0% |
| Pain |
3.8% |
| Prophylaxis |
3.5% |
| Type 2 Diabetes Mellitus |
3.2% |
| Depression |
2.1% |
| Asthma |
1.5% |
| Renal Failure Chronic |
1.5% |
| Constipation |
1.3% |
| Sedation |
1.3% |
| Shock |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Blood Pressure |
1.0% |
| Diabetes Mellitus Insulin-dependent |
1.0% |
| Schizophrenia |
0.9% |
|
| Weight Decreased |
23.4% |
| Blood Glucose Increased |
12.4% |
| Vomiting |
11.7% |
| Nausea |
8.5% |
| Weight Increased |
5.2% |
| Type 2 Diabetes Mellitus |
4.3% |
| Pneumonia |
3.2% |
| Myocardial Infarction |
2.9% |
| Pain |
2.7% |
| Syncope |
2.7% |
| Tremor |
2.7% |
| White Blood Cell Count Decreased |
2.5% |
| Drug Ineffective |
2.3% |
| Hyperglycaemia |
2.3% |
| Renal Failure Acute |
2.3% |
| Urticaria |
2.3% |
| Pulmonary Embolism |
2.2% |
| Type 1 Diabetes Mellitus |
2.2% |
| Dyspnoea |
2.0% |
| Rash |
2.0% |
|
